Skip to main content

Advertisement

Table 2 Association between INAVA expression and clinicopathologic parameters in PTC patients

From: INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression

Clinicopathologic variables (n) INAVA P value
Low High
Age (years)
 < 45 (59) 32 27 0.455
 ≥ 45 (53) 25 28  
Gender
 Male (23) 12 11 0.890
 Female (89) 45 44  
TNM stage
 I and II (73) 44 29 0.007
 III and IV (39) 13 26  
T classification
 T1 and T2 (69) 40 29 0.058
 T3 and T4 (43) 17 26  
Lymph node metastasis
 No (58) 37 21 0.005
 Yes (54) 20 34